References
- 1. Barnes L, Eveson JW. (eds.) WHO Classification of Tumors. Pathology and Genetics of Head and Neck Tumors. IARCPress: Lyon; 2017.
- 2. Aleksić A, Gajanin R, Djurdjević D, Novaković Z, Vranjes D, Spremo S, Travar D, Guzina-Golac N, Tomić-Spirić V. Melanoma of the sinonasal mucosa: A report on the two cases and a review of the literature. Vojnosanit Pregl. 2015;72(10):937-41.
- 3. Wagner M, Morris CG, Werning JW, Mendenhall WM. Mucosal melanoma of the head and neck. Am J Clin Oncol. 2008;31(1):43−8. DOI: 10.1097/COC.0b013e318134ee88.
- 4. Seetharamu N, Ott PA, Pavlick AC. Mucosal melanomas: A case-based review of the literature. Oncologist. 2010;15(7):772−81. DOI: 10.1634/theoncologist.2010-0067. Epub 2010 Jun 22.10.1634/theoncologist.2010-0067.Epub2010Jun22
- 5. Dauer EH, Lewis JE, Rohlinger AL, Weaver AL, Olsen KD. Sinonasal melanoma: a clinicopathologic review of 61 cases. Otolaryngol Head Neck Surg. 2008;138(3):347−52. DOI: 10.1016/j.otohns.2007.12.013.10.1016/j.otohns.2007.12.013
- 6. Temam S, Mamelle G, Marandas P, Wibault P, Avril M, Janot F, et al. Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer. 2005;103(2):313−9.
- 7. Carvajal RD, Spencer SA, Lydiatt W. Mucosal melanoma: a clinically and biologically unique disease entity. J Natl Compr Canc Netw. 2012;10(3):345-56.
- 8. Schaefer T, Satzger I, Gutzmer R. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients. Medicine (Baltimore). 2017;96(1):e5753. DOI: 10.1097/MD.0000000000005753.
- 9. Moreno MA, Roberts DB, Kupferman ME, DeMonte F, El-Naggar AK, Williams M, et al. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M.D. Anderson Cancer Center. Cancer. 2010;116(9):2215-23. DOI: 10.1002/cncr.24976.10.1002/cncr.24976
- 10. Alves IS, Berriel LG, Alves RT, Pinto MB, Oliveira CF, Cazzotto AC, et al. Sinonasal Melanoma: A Case Report and Literature Review. Case Rep Oncol Med. 2017;2017:8201301. DOI: 10.1155/2017/8201301. Epub 2017 Jan 31.
- 11. Lincoln RP. A case of melano-sarcoma of the nose cured by galvanocauterization. N Y Med J. 1885;42:406–7.
- 12. Gilain L, Houette A, Montalban A, Mom T, Saroul N. Mucosal melanoma of the nasal cavity and paranasal sinuses. European Annals of Otorhinolaryngology, Head and Neck Diseases. 2014;131(6):365-9.
- 13. Wong JH, Cagle LA, Storm FK, Morton DL. Natural history of surgically treated mucosal melanoma. Am J Surg. 1987;154(1):54-7.
- 14. Axéll T, Hedin CA. Epidemiologic study of excessive oral melanin pigmentation with special reference to the influence of tobacco habits. Scand J Dent Res. 1982;90(6):434–42.
- 15. Göde S, Turhal G, Tarhan C, Yaman B, Kandiloğlu G, Öztürk K, et al. Primary Sinonasal Malignant Melanoma: Effect of Clinical and Histopathologic Prognostic Factors on Survival. Balkan Med J. 2017;34(3):255-62. DOI: 10.4274/balkanmedj.2016.0503. Epub 2017 Apr 6.10.4274/balkanmedj.2016.0503.Epub2017Apr6
- 16. Ascierto PA, Accorona R, Botti G, Farina D, Fossati P, Gatta G, et al. Mucosal melanoma of the head and neck. Critical Reviews in Oncology / Hematology. 2017;112:136-52. DOI: 10.1016/j.critrevonc.2017.01.019.10.1016/j.critrevonc.2017.01.019
- 17. Saint-Blancard P, Kossowski M. Mélanomes des muqueuses nasosinusiennes. Presse Med. 2006;35(11 Part 1):1664–7.
- 18. Keraliya AR, Krajewski KM, Braschi-Amirfarzan M, et al. Extracutaneous melanomas: a primer for the radiologist. Insights Imaging. 2015;6(6):707-17. DOI: 10.1007/s13244-015-0427-8.10.1007/s13244-015-0427-8
- 19. Yoshioka H, Kamada T, Kandatsu S, Koga M, Yoshikawa K, Matsuoka Y, et al. MRI of mucosal malignant melanoma of the head and neck. J Comput Assist Tomogr. 1998;22(3):492–7.
- 20. Snyder ML, Paulino AF. Melan-A as a useful diagnostic immunohistochemical stain for the diagnosis of primary sinonasal melanomas. Head Neck. 2002;24(1):52-5.
- 21. Yu CH, Chen HH, Liu CM, Jeng YM, Wang JT, Wang YP, et al. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas. J Oral Pathol Med. 2005;34(9):540–5.10.1111/j.1600-0714.2005.00340.x
- 22. Bishop PW. An immunohistochemical vademecum. Available at http://e-immunohistochemistry.info/web/histopathology_help.htm. Version date October 2012.
- 23. Prasad ML, Jungbluth AA, Iversen K, Huvos AG, Busam KJ. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa. Am J Surg Pathol. 2001;25(6):782-7.10.1097/00000478-200106000-00010
- 24. Weinstein D, Leininger J, Hamby C, Safai B. Diagnostic and prognostic biomarkers in melanoma. J Clin Aesthet Dermatol. 2014;7(6):13-24.
- 25. Modabbernia S, Bashardoust N, Bagheri SS. Malignant Mucosal Melanoma of the Maxillary Sinus. Journal of Dentomaxillofacial Radiology, Pathology and Surgery. 2017;5(4):32-6.
- 26. Nonaka D, Chiriboda L, Rubin BP. SOX10: a pan-schwannian and melanocytic marker. Am J Surg Pathol. 2008;32(9):1291–8. DOI: 10.1097/PAS.0b013e3181658c14.
- 27. Gershon TR, Oppenheimer O, Chin SS, Gerald WL. Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation. Neoplasia. 2005;7(6):575–84.10.1593/neo.04637
- 28. Kelsch RN. Sorting out SOX10 functions in neural crest development. Bioessays. 2006;28(8):788-98.
- 29. Liu HG, Kong MX, Yao Q, Wang SY, Shibata R, Yee H, et al. Expression of Sox10 and c-kit in sinonasal mucosal melanomas arising in the Chinese population. Head Neck Pathol. 2012;6(4):401–8. DOI: 10.1007/s12105-012-0375-2. Epub 2012 Jun 27.
- 30. Jennings C, Kim J. Identification of nodal metastases in melanoma using sox-10. Am J Dermatopathol. 2011;33(5):474–82. DOI: 10.1097/DAD.0b013e3182042893.
- 31. Medina JE, Ferlito A, Pellitteri PK, Shaha AR, Khafif A, Devaney KO, et al. Current management of mucosal melanoma of the head and neck. J Surg Oncol. 2003;83(2):116–22.10.1002/jso.10247
- 32. Zebary A, Jangard M, Omholt K. KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases. Br J Cancer. 2013;109(3):559-64. DOI: 10.1038/bjc.2013.373. Epub 2013 Jul 16.10.1038/bjc.2013.373.Epub2013Jul16
- 33. Sullivan RJ, Flaherty K. MAP kinase signaling and inhibition in melanoma. Oncogene. 2013;32(19):2373–9. DOI: 10.1038/onc.2012.345. Epub 2012 Sep 3.10.1038/onc.2012.345.Epub2012Sep3
- 34. Turri–Zanoni M, Medicina D, Lombardi D, Ungari M, Balzarini P, Rossini C, et al. Sinonasal mucosal melanoma: Molecular profile and therapeutic implications from a series of 32 cases. Head Neck. 2013;35(8):1066-77. DOI: 10.1002/hed.23079. Epub 2012 Jul 12.
- 35. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364:2507–16. DOI: 10.1056/NEJMoa1103782.10.1056/NEJMoa1103782
- 36. Hauschild A, Grob JJ, Demidov LV, Jouray T, Gutzmer R, Millward M, et al. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, openlabel, phase 3 randomised controlled trial. Lancet. 2012;380(9839):358–65. DOI: 10.1016/S0140-6736(12)60868-X. Epub 2012 Jun 25.10.1016/S0140-6736(12)60868-X.Epub2012Jun25
- 37. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. (Eds.). AJCC Cancer Staging Manual. Eighth Edition. Springer International Publishing; 2017.
- 38. Enee V, Houliat T, Truilhe Y, Darrouzet V, Stoll D. Malignant melanoma of the nasosinal mucosa. Retrospective study apropos of 20 cases. Rev Laryngol Otol Rhinol (Board). 2000;121(4):243–50.
- 39. Clifton N, Harrison L, Bradley PJ, Jones NS. Malignant melanoma of nasal cavity and paranasal sinuses: report of 24 patients and literature review. J Laryngol Otol. 2011;125(5):479–85. DOI: 10.1017/S0022215110002720. Epub 2011 Jan 21.10.1017/S0022215110002720.Epub201121
- 40. Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, et al. Mucosal Melanoma of the Head and Neck: Clinical Practice Guidelines in Oncology. JNCCN. 2012;10(3):320-38.
- 41. Dirix P, Vanstraelen B, Jorissen M, Vander Poorten V, Nuyts S. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy. Int J Radiat Oncol Biol Phys. 2010;78(4):998–1004. DOI: 10.1016/j.ijrobp.2009.09.067. Epub 2010 Mar 24.10.1016/j.ijrobp.2009.09.067.Epub201024
- 42. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664-78.
- 43. Khan MN, Kanumuri VV, Raikundalia MD, et al. Sinonasal melanoma: survival and prognostic implications based on site of involvement. Int Forum Allergy Rhinol. 2014;4(2):151-5. DOI: 10.1002/alr.21243. Epub 2013 Nov 4.10.1002/alr.21243.Epub2013Nov4
- 44. Gore MR, Zanation AM. Survival in Sinonasal Melanoma: A Meta-analysis. J Neurol Surg B Skull Base. 2012;73(3):157-62. DOI: 10.1055/s-0032-1301400.10.1055/s-0032-1301400
- 45. Bachar G., Loh KS, O’Sullivan B, et al. Mucosal melanomas of head and neck: experience of the Princess Margaret Hospital. Head Neck. 2008;30(10):1325-31. DOI: 10.1002/hed.20878.